Abstract
Catechol-O-methyltransferase (COMT) is involved in the metabolism of neurotransmitters such as epinephrine, norepinephrine and dopamine. For melanocytes, the enzyme is of particular importance in preventing the formation of toxic o-quinones during melanin synthesis. It has been suggested that COMT plays a regulatory role in melanin synthesis. Indeed, when the melanin precursor molecule DHI(2C) is methylated by COMT it is no longer available for incorporation into melanin. Autodestruction by intermediates of melanin metabolism has been implicated in the aetiology of vitiligo. Therefore enzyme activities in vitiligo patients and in healthy controls were compared. Systemic COMT activities were measured using red blood cells (RBC) as starting material. However, as local alterations in COMT activity may be specifically involved in vitiligo, the enzyme activity was also measured in epidermal homogenates. Finally, to ascribe epidermal COMT activity to the responsible cell type(s), enzyme activity was measured in cultured vitiligo non-lesional melanocytes and melanocytes from healthy controls as well as in cultured keratinocytes from lesional skin and in purified keratinocytes from control skin. It was found that epidermal homogenates from vitiligo patients expressed higher levels of COMT activity than homogenates from healthy controls. Such differences were not found at the systemic level (i.e. in RBC) nor could they be explained by measurements on separately cultured epidermal cell types, indicating that the COMT activity was induced at the tissue level by extracellular factors. It is possible that elevated levels of catecholamines secreted by keratinocytes or by nerve endings in vitiliginous skin in close proximity to the epidermis cause damage to all epidermal cells, an effect which is insufficiently neutralized by elevated levels of COMT activity. Catecholamines may well be more damaging to the melanocytes than to the keratinocytes because of their slower turnover rate.
Similar content being viewed by others
References
Bamshad J, Lerner AB, McGuire JS (1964) Catechol O-methyltransferase in skin. J Invest Dermatol 43: 111–113
Bhawan J, Bhutani LK (1983) Keratinocyte damage in vitiligo. J Cutan Pathol 10: 207–212
Brahe C, Banetta P, Meera Khan P, Arwert F, Serra A (1986) Assigment of the catechol-O-methyltransferase gene to human chromosome 22 in somatic cell hybrids. Hum Genet 74: 230–234
Cohn CK, Dunner DL, Axelrod J (1970) Reduced catechol-O-methyltransferase in red blood cells of women with primary affective disorder. Science 170: 1323–1324
De Luca M, D'Anna F, Bondanza S, Franzi AT, Cancedda R (1988) Human epithelial cells induce human melanocyte growth in vitro but only skin keratinocytes regulate its proper differentiation in the absence of dermis. J Cell Biol 107: 1919–1926
Eisinger M, Marko O (1982) Selective proliferation of normal human melanocytes in vitro in presence of phorbol ester and cholera toxin. Proc Natl Acad Sci USA 79: 2018–2022
Floderus Y, Ross SB, Wetterberg L (1981) Erythrocyte catechol-O-methyltransferase activity in a Swedish population. Clin Genet 19: 389–392
Goldstein M, Liebermann A (1992) The role of regulatory enzymes of catecholamine synthesis in Parkinson's disease. Neurology 42 [Suppl 4]: 8–12
Grossmann MH, Budarf M (1992) Chromosomal mapping of the human catechol-O-methyltransferase gene to 22q11.1 → 11.2. Genomics 12: 822–825
Gustavson KH, Wetterberg L, BÄckström M, Ross SB (1973) Catechol-O-methyltransferase in erythrocytes in Down's syndrome. Clin Genet 4: 279–280
Holbrook KA, Vogel AM, Underwood RA, Foster CA (1988) Melanocytes in human embryonic and fetal skin: a review and new findings. Pigment Cell Res [Suppl 1]: 6–17
Le Poole IC, Wijngaard RMJGJ van den, Westerhof W, Dutrieux RP, Das PK (1993) Absence or presence of melanocytes in vitiligo lesions: an immunohistochemical investigation. J Invest Dermatol 100: 816–822
Lerner AB (1971) On the etiology of vitiligo and gray hair. Am J Med 51: 141–147
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193: 265–275
Lundström K, Tilgmann C, PerÄnen J, Kalkkinen N, Ulmanen I (1992) Expression of enzymatically active rat liver and human placental catechol-O-methyltransferase in Escherichia coli; purification and partial characterization of the enzyme. Biochim Biophys Acta 1129: 149–154
Malherbe P, Bertolucci B, Caspers P, Zurcher G, Da Prada M (1992) Expression of functional membrane-bound and soluble catechol-O-methyltransferase in Escherichia coli and a mammalian cell line. J Neurochem 58: 1782–1789
Moellmann G, Klein-Angerer S, Scollay DA, Nordlund JJ, Lerner AB (1982) Extracellular granular material and degeneration of keratinocytes in the normally pigmented epidermis of patients with vitiligo. J Invest Dermatol 79: 321–330
Morrone A, Picardo M, De Luca C, Terminali O, Passi S, Ippolito F (1992) Catecholamines and vitiligo. Pigment Cell Res 5: 65–69 (1992)
Morrone A, Passi S, Picardo M, De Luca C (1992b) (abstract). Pigment Cell Res 5: 90
Pavel S, Muskiet FAJ, De Lay L, The TH, Van der Slik W (1983) Identification of three indolic compounds on a pigmented melanoma cell culture supernatant by gas chromatography-mass spectrometry. J Cancer Res Clin Oncol 105: 275–279
Pennings EJM, Van Kempen GMJ (1979) Assay of catechol-O-methyltransferase by determination of the m- and p-O-methylated products using high performance liquid chromatography. Anal Biochem 98: 452–454
Raymond FA, Weinshilboum RM (1975) Microassay of human erythrocyte catechol-O-methyltransferase: Removal of inhibitory calcium ion with chelating resin. Clin Chim Acta 58: 185–194
Rheinwald JG, Green H (1975) Serial cultivation of human epidermal keratinocytes: the formation of keratinizing colonies from single cells. Cell 6: 331–334
Schallreuter KU, Pittelkow MR (1988) Defective calciumuptake in keratinocyte cell cultures from vitiliginous skin. Arch Dermatol Res 280: 137–139
Schallreuter KU, Pittelkow MR, Wood JM (1986) Free radical reduction by thioredoxin reductase at the surface of normal and vitiliginous human keratinocytes. J Invest Dermatol 87: 728–732
Schallreuter KU, Hordinsky MK, Wood JM (1987) Thioredoxin reductase-role in free radical reduction in different hypopigmentation disordes. Arch Dermatol 123: 615–619
Schallreuter KU, Wood JM, Berger J (1991) Low catalase levels in the epidermis of patients with vitiligo. J Invest Dermatol 97: 1081–1085
Schallreuter KU, Wood JM, Lemke R, Le Poole C, Das P, Westerhof W, Pittelkow MR, Thody AJ (1993a) Production of catecholamines in the human epidermis. Biochem Biophys Res Commun 189: 72–78
Schallreuter KU, Wood JM, Pittelkow MR, Swanson NN, Steinkraus V. (1993b) Increased in vitro expression of beta2-adrenoceptors in differentiating lesional keratinocytes of vitiligo patients. Arch Dermatol Res 285: 216–220
Shelley WB, öhman S (1969) Epinephrin induction of white hair in ACI rats. J Invest Dermatol 53: 155–158
Shibata T, Pavel S, Smit N, Ichihashi M, Mishima Y (1993) Differences in subcellular distribution of catechol-O-methyltransferase and tyrosinase in malignant melanoma. J Invest Dermatol 100: 222S-225S
Smit NPM, Latter TC, Naish-Byfiels S, Westerhof W, Pavel S, Riley PA (1992) (abstract) Catechol-O-methyltransferase as a target for melanoma destruction. Pigment Cell Res 5: 202
Smit NPM, Pavel S, Kammeyer A, Westerhof W (1990) Determination of catechol-O-methyltransferase in relation to melanin metabolism using high performance liquid chromatagraphy with fluorimetric detection. Anal Biochem 190: 286–291
Tilgmann C, Kalkkinen N (1991) Purification and partial sequence analysis of the soluble catechol-O-methyltransferase from human placenta: comparison to the rat liver enzyme. Biochem Biophys Res Commun 174: 995–1002
Vennegoor C, Hageman P, Nouhuys H van, Ruiter DJ, Calafat J, Ringens PJ, Rümke P (1988) A monoclonal antibody specific for cells of the melanocyte lineage. Am J Pathol 130: 179–192
Wakamatsu K, Ito S, Fujita K (1990) Production, circulation and excretion of melanin-related metabolites in B16 melanomabearing mice. Acta Derm Venereol (Stockh) 70: 367–372
Weinshilbaum RM, Raymond FA (1976) Calcium inhibition of rat liver catechol-O-methyltransferase. Biochem Pharmacol 25: 573–579
Weinshilbaum RM, Raymond FA (1977) Inheritance of low erythrocyte catechol-O-methyltransferase activity in man. Am J Hum Genet 29: 125–135
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Le Poole, I.C., van den Wijngaard, R.M.J.G.J., Smit, N.P.M. et al. Catechol-O-methyltransferase in vitiligo. Arch Dermatol Res 286, 81–86 (1994). https://doi.org/10.1007/BF00370732
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00370732